Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- ChecktodayNo Change Detected
 - Check7 days agoChange DetectedNo substantive changes detected between the two screenshots; the page still presents the Study Details for NCT01740297 with the same sections (Overview, Eligibility Criteria, Plan, Contacts and Locations).SummaryDifference0.3%

 - Check22 days agoChange DetectedRemoved the MedlinePlus Genetics topic Melanoma from the page, reducing the page’s coverage of genetic topics related to melanoma.SummaryDifference0.1%

 - Check29 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference2%

 - Check36 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

 - Check50 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; no changes to core content or pricing, and a Back to Top element was removed (a minor UI change).SummaryDifference0.1%

 - Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

 
Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.